Atlas Trials

Combination Therapy With Ursodeoxycholic Acid (UDCA) and All-Trans Retinoic Acid (ATRA) for Treatment of Primary Sclerosing Cholangitis

Clinical trial NCT01456468 · COMPLETED

Trial details

NCT number
NCT01456468
Sponsor
Yale University
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Cholangitis, Sclerosing
Start date
2011-10-01
Primary completion
2014-06-01
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.